UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Comprehensive overview of the recently FDA-approved contraceptive vaginal ring releasing segesterone acetate and ethinylestradiol: A new year-long, patient controlled, reversible birth control method

Expert review of clinical pharmacology, 2019-10, Vol.12 (10), p.953-963

Nelson, Anita L.

2019

Volltextzugriff (PDF)

Pharmacokinetics and pharmacodynamics of three dosages of oestriol after continuous vaginal ring administration for 21 days in healthy, postmenopausal women

British journal of clinical pharmacology, 2019-03, Vol.85 (3), p.551-562

2019

Volltextzugriff (PDF)

A randomized study on pharmacodynamic effects of vaginal rings delivering the progesterone receptor modulator ulipristal acetate: research for a novel estrogen-free, method of contraception

Contraception (Stoneham), 2014-12, Vol.90 (6), p.565-574

2014

Volltextzugriff (PDF)

“Per vaginam” topical use of hormonal drugs in women with symptomatic deep endometriosis: a narrative literature review

Archives of gynecology and obstetrics, 2017-09, Vol.296 (3), p.435-444

2017

Volltextzugriff (PDF)

Vaginal ring contraception

Contraception (Stoneham), 2011-02, Vol.83 (2), p.107-115

2011

Volltextzugriff (PDF)

Combined Contraceptive Vaginal Ring-its Acceptability in Indian Women

Indian journal of public health research and development., 2016, Vol.7 (1), p.57

2016

Volltextzugriff (PDF)

Vaginal Administration of Contraceptives

Scientia pharmaceutica, 2021-12, Vol.89 (1), p.3

2021

Volltextzugriff (PDF)

Microbicide vaginal rings: Technological challenges and clinical development

Advanced drug delivery reviews, 2016-08, Vol.103, p.33-56

2016

Volltextzugriff (PDF)

Advances in long-acting injectables, implants, and vaginal rings for contraception and HIV prevention

Advanced drug delivery reviews, 2021-09, Vol.176, p.113849-113849, Article 113849

2021

Volltextzugriff (PDF)

3D printing of vaginal rings with personalized shapes for controlled release of progesterone

International journal of pharmaceutics, 2018-03, Vol.539 (1-2), p.75-82

2018

Volltextzugriff (PDF)

Emerging Trends and Potential Prospects in Vaginal Drug Delivery

Current drug delivery, 2023-01, Vol.20 (6), p.730-751

2023

Volltextzugriff (PDF)

Dapivirine-releasing vaginal rings produced by plastic freeforming additive manufacturing

International journal of pharmaceutics, 2019-12, Vol.572, p.118725-118725, Article 118725

2019

Volltextzugriff (PDF)

Progesterone vaginal ring as a new contraceptive option for lactating mothers: Evidence from a multicenter non-randomized comparative clinical trial in India

Contraception (Stoneham), 2020-09, Vol.102 (3), p.159-167

2020

Volltextzugriff (PDF)

Risk factors for and outcomes of ring expulsions with a 1-year contraceptive vaginal system

American journal of obstetrics and gynecology, 2024-05, Vol.230 (5), p.548.e1-548.e8

2024

Volltextzugriff (PDF)

Vaginal ring acceptability: A systematic review and meta-analysis of vaginal ring experiences from around the world

Contraception (Stoneham), 2022-02, Vol.106, p.16-33

2022

Volltextzugriff (PDF)

Contraception technology: past, present and future

Contraception (Stoneham), 2013-03, Vol.87 (3), p.319-330

2013

Volltextzugriff (PDF)

Novel drug delivery methods for improving efficacy of endometriosis treatments

Expert opinion on drug delivery, 2021-03, Vol.18 (3), p.355-367

2021

Volltextzugriff (PDF)

The effect of different contraceptive methods on the vaginal microbiome

Expert review of clinical pharmacology, 2021-07, Vol.14 (7), p.821-836

2021

Volltextzugriff (PDF)

Phase 1 Safety, Pharmacokinetics, and Pharmacodynamics of Dapivirine and Maraviroc Vaginal Rings: A Double-Blind Randomized Trial

Journal of acquired immune deficiency syndromes (1999), 2015-11, Vol.70 (3), p.242-249

2015

Volltextzugriff (PDF)

Acceptability and Preference for 3-Month Versus 1-Month Vaginal Rings for HIV-1 Risk Reduction Among Participants in a Phase 1 Trial

Journal of women's health (Larchmont, N.Y. 2002), 2022-07, Vol.31 (7), p.1029-1039

2022

Volltextzugriff (PDF)

Contraceptive Technologies: Looking Ahead to New Approaches to Increase Options for Family Planning

Clinical obstetrics and gynecology, 2021-09, Vol.64 (3), p.435-448

2021

Volltextzugriff (PDF)

Phase 2a Safety, Pharmacokinetics, and Acceptability of Dapivirine Vaginal Rings in US Postmenopausal Women

Clinical infectious diseases, 2019-03, Vol.68 (7), p.1144-1151

2019

Volltextzugriff (PDF)

Non-oral routes, novel formulations and devices of contraceptives: An update

Journal of controlled release, 2022-05, Vol.345, p.798-810

2022

Volltextzugriff (PDF)

Hormonal Contraception: Systemic Estrogen and Progestin Preparations

Clinical obstetrics and gynecology, 2021-12, Vol.64 (4), p.721-738

2021

Volltextzugriff (PDF)

Acceptability and use of a dapivirine vaginal ring in a phase III trial

AIDS (London), 2017-05, Vol.31 (8), p.1159-1167

2017

Volltextzugriff (PDF)

1 – 25 von 509

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(468)
Mit Volltextzugriff
(391)

Publikationsform

Artikel
(487)
Buchkapitel
(20)
Bücher
(1)
Reviews
(1)

Sprache

1 weiteren anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(420)
Life Sciences & Biomedicine
(416)
Humans
(336)
Female
(335)
Vaginal Ring
(226)
Obstetrics & Gynecology
(205)
Contraceptive Devices, Female
(161)
Adult
(156)
Biological And Medical Sciences
(119)
Medical Sciences
(114)
Birth Control
(97)
Adolescent
(91)
Vagina
(90)
Contraception
(86)
Administration, Intravaginal
(79)
Public, Environmental & Occupational Health
(79)
Hiv
(77)
Pharmacology & Pharmacy
(77)
Gynecology. Andrology. Obstetrics
(74)
Hiv Infections - Prevention & Control
(73)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Comprehensive overview of the recently FDA-approved contraceptive vaginal ring releasing segesterone acetate and ethinylestradiol: A new year-long, patient controlled, reversible birth control method

Pharmacokinetics and pharmacodynamics of three dosages of oestriol after continuous vaginal ring administration for 21 days in healthy, postmenopausal women

A randomized study on pharmacodynamic effects of vaginal rings delivering the progesterone receptor modulator ulipristal acetate: research for a novel estrogen-free, method of contraception

“Per vaginam” topical use of hormonal drugs in women with symptomatic deep endometriosis: a narrative literature review

Vaginal ring contraception

Combined Contraceptive Vaginal Ring-its Acceptability in Indian Women

Vaginal Administration of Contraceptives

Microbicide vaginal rings: Technological challenges and clinical development

Advances in long-acting injectables, implants, and vaginal rings for contraception and HIV prevention

3D printing of vaginal rings with personalized shapes for controlled release of progesterone

Emerging Trends and Potential Prospects in Vaginal Drug Delivery

Dapivirine-releasing vaginal rings produced by plastic freeforming additive manufacturing

Progesterone vaginal ring as a new contraceptive option for lactating mothers: Evidence from a multicenter non-randomized comparative clinical trial in India

Risk factors for and outcomes of ring expulsions with a 1-year contraceptive vaginal system

Vaginal ring acceptability: A systematic review and meta-analysis of vaginal ring experiences from around the world

Contraception technology: past, present and future

Novel drug delivery methods for improving efficacy of endometriosis treatments

The effect of different contraceptive methods on the vaginal microbiome

Phase 1 Safety, Pharmacokinetics, and Pharmacodynamics of Dapivirine and Maraviroc Vaginal Rings: A Double-Blind Randomized Trial

Acceptability and Preference for 3-Month Versus 1-Month Vaginal Rings for HIV-1 Risk Reduction Among Participants in a Phase 1 Trial

Contraceptive Technologies: Looking Ahead to New Approaches to Increase Options for Family Planning

Phase 2a Safety, Pharmacokinetics, and Acceptability of Dapivirine Vaginal Rings in US Postmenopausal Women

Non-oral routes, novel formulations and devices of contraceptives: An update

Hormonal Contraception: Systemic Estrogen and Progestin Preparations

Acceptability and use of a dapivirine vaginal ring in a phase III trial

Suchergebnisse filtern